Suppr超能文献

肥胖症手术后腹腔内布比卡因灌注的疗效:随机对照试验。

Efficacy of Intraperitoneal Instillation of Bupivacaine after Bariatric Surgery: Randomized Controlled Trial.

机构信息

Bariatric Surgery Unit, King Hamad University Hospital, Al Sayh, Kingdom of Bahrain.

出版信息

Obes Surg. 2019 Jun;29(6):1735-1741. doi: 10.1007/s11695-019-03775-x.

Abstract

INTRODUCTION

Obesity is one of the greatest health problems. Bariatric surgery is more effective than non-surgical options; however, postoperative pain is bound to a greater morbidity. Control of postoperative pain is important in facilitating patient convalescence. In this study, we assessed the efficacy of intraperitoneal instillation of bupivacaine after bariatric surgery.

METHODS

A hundred patients who underwent bariatric procedures including sleeve gastrectomy, sleeve gastrectomy with cardioplasty, gastric bypass, and gastric mini bypass (one anastomosis gastric bypass) were included in the study. Patients were divided into two groups randomly, 50 patients for each; group I had intraperitoneal instillation of 40 ml bupivacaine 0.25% at the end of the procedure, while group II had normal saline instillation. Monitoring of pain control in the first 24 h after surgery was done using the visual analogue scale (VAS) to assess the efficacy of intraperitoneal bupivacaine instillation and its effect on the overall opioid usage, postoperative nausea and vomiting (PONV), and shoulder tip pain.

RESULTS

Pain scores were significantly lower in group I compared to group II at recovery, 2, 4 and 6 h after surgery, P = 0.004, 0.001, < 0.001, and 0.001 respectively. However, there were no significant differences between 12 and 24 h postoperatively. Additionally, there was a significant difference regarding the need for rescue analgesia at recovery P = < 0.001. Further analysis revealed lower morphine consumption via PCA in group I compared to group II P = 0.013. There were no significant differences with the use of intraperitoneal bupivacaine as regards nausea, vomiting, or shoulder tip pain, P = 0.688, 0.249, and 0.487, respectively.

CONCLUSIONS

Intraperitoneal instillation of bupivacaine provides a good analgesia in the early postoperative period, reduces the overall consumption of opioid, and decreases the rescue analgesia requirement in the first 24 h after surgery.

摘要

简介

肥胖是最大的健康问题之一。减重手术比非手术方法更有效;然而,术后疼痛必然会导致更高的发病率。控制术后疼痛对于促进患者康复很重要。在这项研究中,我们评估了肥胖手术后腹腔内注射布比卡因的疗效。

方法

本研究纳入了 100 例接受减重手术的患者,包括袖状胃切除术、袖状胃切除术加心脏成形术、胃旁路术和胃迷你旁路术(单吻合口胃旁路术)。患者随机分为两组,每组 50 例;组 I 在手术结束时腹腔内灌注 40ml 0.25%布比卡因,组 II 则灌注生理盐水。术后 24 小时内使用视觉模拟评分(VAS)监测疼痛控制情况,评估腹腔内布比卡因灌注的疗效及其对整体阿片类药物使用、术后恶心呕吐(PONV)和肩部疼痛的影响。

结果

与组 II 相比,组 I 在恢复时、手术后 2、4 和 6 小时的疼痛评分明显较低,P=0.004、0.001、<0.001 和 0.001。然而,术后 12 和 24 小时之间没有显著差异。此外,在恢复时,需要挽救性镇痛的差异有统计学意义,P=0.001。进一步分析显示,与组 II 相比,组 I 通过 PCA 消耗的吗啡明显较少,P=0.013。在使用腹腔内布比卡因方面,恶心、呕吐或肩部疼痛没有显著差异,P=0.688、0.249 和 0.487。

结论

腹腔内注射布比卡因可在术后早期提供良好的镇痛效果,减少阿片类药物的整体消耗,并降低术后 24 小时内的挽救性镇痛需求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验